New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

After a nearly two-year ordeal, some answers have been determined in the TOPCon intellectual property lawsuit between Maxeon ...

Propanc Biopharma, Inc. (Nasdaq: PPCB) is developing a novel approach to preventing cancer recurrence and metastasis by targeting and eradicating cancer stem cells through proenzyme activation. The ...

Cary Claiborne, President and Chief Executive Officer of Adial, commented, “As we continue to advance the AD04 program with planning for the next phase of our clinical program, the new patent ...

NAPLES, Fla. and CAMBRIDGE, United Kingdom - CDT Equity Inc. (NASDAQ:CDT) has engaged NJS Foresight Bio-Advisory, LLC to identify and execute out-licensing opportunities for selected assets within its ...

· Evenamide is a first-in-class glutamate modulator with a novel mechanism of action for patients who do not respond adequately, or are resistant to, existing antipsychotic therapies · ENIGMA-TRS ...

© 2026 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

The Office of Undergraduate Admissions continues to put students first in the admissions process. We continue to use fair and ethical practices as we recruit, review applications and counsel our ...

Who goes to Smith? We could quote statistics on geographic distribution, class rank and College Board examination scores. But statistics do little to give you a sense of the vibrancy, intelligence and ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Chip Stapleton is a Series 7 and Series 66 license holder, CFA Level 1 exam holder, and currently holds a Life, ...